immpact-bio.com
immpact-bio.com

ImmPACT Bio is dedicated to the discovery of transformative CAR-T cell therapies for cancer patients who have exhausted their treatment options. Our technology is designed to precisely distinguish cancerous cells from normal cells; thereby eliminating tumors without damaging normal tissues. Our goal is to eradicate tumors without generating the severe side effects that are difficult, sometimes impossible, for cancer patients to endure. The company was founded in 2017 in the FuturRx incubator (Israel). In 2019, ImmPACT Bio was incorporated in the US and R&D operations were established in Camarillo, CA. In 2021 ImmPACT Bio merged with Kalthera.
immpact-bio.com

Is this your company?

If you're responsible for hiring at this company, make sure your company and job information are always up to date to attract top talent from the dot.LA network.

Inaccurate data? Flag it here.
Open jobs at immpact-bio.com
We only use strictly necessary, first-party cookies on this job board. These are cookies that are necessary to deliver this service to you, or are necessary for dot.LA to understand how it is being used. Read our Cookie Policy.